Radio frequency ablation of small focal neoplasms has pre viously been demonstrated in other organs, such as the liver and bone. 1, 2 To our knowledge we report the first completely treated case of radio frequency ablation of renal cell carci noma via percutaneous placement of a needle electrode under ultrasound guidance.
CASE REPORT
An 84-year-old man was diagnosed with a solid renal mass and he refused open surgery. Computerized tomography (CT) demonstrated mass enhancement with iodinated contrast material, consistent with solid renal cell carcinoma ( fig. 1 ). Three years later the mass had enlarged to 3.5 cm. The patient continued to refuse surgery but he consented to per cutaneous radio frequency ablation. Institutional review board permission was obtained before the procedure.
The patient underwent conscious sedation with 2 mg. mi dazolam and 150 mg. fentanyl given intravenously as well as 1% lidocaine given subcutaneously. Immediately before ab lation percutaneous needle biopsy confirmed the diagnosis of renal cell carcinoma. A 17 gauge, internally cooled radio frequency needle electrode was placed percutaneously under real-time ultrasound guidance into the center of the lesion. Goldberg 1 and Solbiati 2 et al have shown that these elec trodes induce large volumes of coagulation necrosis in liver tumors. The tumor was heated to 90C for 1 minute, followed by deposition of 1,200 mA. for 12 minutes. Ultrasonography revealed progressive hyperechogenicity enveloping the lesion during treatment. After ablation temperatures remained at greater than 60C for 3.5 minutes. The electrode was removed without incident.
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The patient was awake, comfortable and conversant, and vital signs were stable throughout the procedure as well as during 2 hours of postoperative monitoring. CT 2 hours post operatively revealed a 3.5 cm. nonenhancing region envelop ing the previously enhancing tumor, and no evidence of com plications, such as bleeding or urinoma ( fig. 2) .
The patient was discharged home in stable condition. He was followed closely during the following month, and he reported no flank pain or hematuria. Followup imaging at 1 and 3 months showed persistent nonenhancement of the treated region with no evidence of peripheral enhancement suggestive of residual viable tumor.
DISCUSSION
With the advent of abdominal CT and magnetic resonance imaging the detection of small asymptomatic renal tumors has increased. While the standard of care dictates radical or partial nephrectomy, many patients with this incidental finding are poor surgical candidates due to advanced age or co-morbid disease. We present a new minimally invasive treatment alternative for these lesions involving radio fre quency ablation using a needle electrode placed percutane ously under ultrasound guidance. Zlotta et al reported that this radio frequency technique is safe ex vivo and in vivo perioperatively. 3 It may be performed on an outpatient basis using conscious sedation. Postoperatively imaging findings are similar to those reported by Goldberg 1 and Solbiati 2 et al for liver tumor ablation.
Fat surrounding a kidney lesion may provide an insulating effect that results in greater heat retention and, thus, more tumor cell death compared to the liver. 1, 2 Radio frequency ablation warrants additional future study with extended fol lowup to determine long-term efficacy. In conclusion, suc cessful percutaneous ablation may prove to be a reasonable 
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RADIO FREQUENCY ABLATION OF RENAL CELL CANCER treatment alternative in patients who are at significant op erative risk or when renal preservation is desired, such as those in whom von-Hippel Lindau disease or other conditions predispose to multiple bilateral renal tumors.
